TetraLogic Pharmaceuticals Corp
TetraLogic Pharmaceuticals Corporation, a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics in oncology and infectious diseases. It has two clinical-stage product candidates in development, such as birinapant and SHAPE. Birinapant is a small molecule therapeutic that mimics Second Mitochondrial Activator of Caspases-mimetic, which leads to… Read more
Market Cap & Net Worth: TetraLogic Pharmaceuticals Corp (TLOG)
TetraLogic Pharmaceuticals Corp (PINK:TLOG) has a market capitalization of $2.45K ($2.45K) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #47195 globally and #14628 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying TetraLogic Pharmaceuticals Corp's stock price $0.00 by its total outstanding shares 24465083 (24.47 Million).
TetraLogic Pharmaceuticals Corp Market Cap History: 2015 to 2025
TetraLogic Pharmaceuticals Corp's market capitalization history from 2015 to 2025. Data shows change from $42.32 Million to $2.45K (-65.11% CAGR).
TetraLogic Pharmaceuticals Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how TetraLogic Pharmaceuticals Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of TLOG by Market Capitalization
Companies near TetraLogic Pharmaceuticals Corp in the global market cap rankings as of March 19, 2026.
Key companies related to TetraLogic Pharmaceuticals Corp by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #165 globally with a market cap of $114.33 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #285 globally with a market cap of $73.32 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #340 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #497 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #165 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $114.33 Billion | $451.59 |
| #285 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $73.32 Billion | $744.12 |
| #340 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #497 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
TetraLogic Pharmaceuticals Corp Historical Marketcap From 2015 to 2025
Between 2015 and today, TetraLogic Pharmaceuticals Corp's market cap moved from $42.32 Million to $ 2.45K, with a yearly change of -65.11%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $2.45K | 0.00% |
| 2024 | $2.45K | 0.00% |
| 2023 | $2.45K | 0.00% |
| 2022 | $2.45K | -98.00% |
| 2021 | $122.33K | -58.33% |
| 2020 | $293.58K | -67.57% |
| 2019 | $905.21K | +428.57% |
| 2018 | $171.26K | -65.00% |
| 2017 | $489.30K | -67.21% |
| 2016 | $1.49 Million | -96.47% |
| 2015 | $42.32 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of TetraLogic Pharmaceuticals Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.45K USD |
| MoneyControl | $2.45K USD |
| MarketWatch | $2.45K USD |
| marketcap.company | $2.45K USD |
| Reuters | $2.45K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.